Multicomponent Physical Activity Intervention for the Reduction of Psychosocial Distress in Cancer Patients

NCT ID: NCT05056831

Last Updated: 2024-10-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-21

Study Completion Date

2024-10-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study adapts and assesses the effect of a multicomponent physical activity intervention in reducing psychosocial distress in cancer patients. This study aims to develop a program to help increase physical activity and reduce stress in cancer survivors who live in rural areas.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. To adapt a multicomponent intervention (HH+AIM) that assesses the perspective of health care provider and cancer survivors about:

Ia. Needs related to psychosocial distress and health behaviors in rural patients with cancer.

Ib. Needs related to implementing interventions within the treatment setting. Ic. Barriers to intervention delivery/participate. Id. Preferred means/methods for referring participants and receiving information related to the intervention.

SECONDARY OBJECTIVES:

I. To assess time spent sitting in prolonged bouts of 20 consecutive minutes or more (minutes/day).

II. To assess daily number of steps (collected using the activPAL over 7 days at week 8, data will be averaging over 7 days to get minutes per day).

III. To assess psychosocial distress measured using the National Comprehensive Cancer Network (NCCN) Distress Thermometer scores.

IV. To assess health-related quality of life measured using the SF-36 short form.

OUTLINE:

PART I: Patients and providers complete a questionnaire and attend an interview over 1 hour.

PART II: Patients are randomized to 1 of 2 groups.

GROUP I: Patients attend face-to-face mind-body sessions focused on stretching, breathing, and relaxation twice a week and receive targeted text messages daily on their smartphone for 8 weeks.

GROUP II: Patients receive usual care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Disorder Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I (physical activity intervention)

Patients attend face-to-face mind-body sessions focused on stretching, breathing, and relaxation twice a week and receive targeted text messages daily on their smartphone for 8 weeks.

Group Type EXPERIMENTAL

Behavioral Intervention

Intervention Type BEHAVIORAL

Attend face-to-face mind-body sessions

Informational Intervention

Intervention Type OTHER

Receive targeted text messages

Quality-of-Life Assessment

Intervention Type OTHER

Ancillary studies

Questionnaire Administration

Intervention Type OTHER

Ancillary studies

Group II (usual care)

Patients receive usual care.

Group Type ACTIVE_COMPARATOR

Best Practice

Intervention Type OTHER

Receive usual care

Quality-of-Life Assessment

Intervention Type OTHER

Ancillary studies

Questionnaire Administration

Intervention Type OTHER

Ancillary studies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Behavioral Intervention

Attend face-to-face mind-body sessions

Intervention Type BEHAVIORAL

Best Practice

Receive usual care

Intervention Type OTHER

Informational Intervention

Receive targeted text messages

Intervention Type OTHER

Quality-of-Life Assessment

Ancillary studies

Intervention Type OTHER

Questionnaire Administration

Ancillary studies

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Behavior Conditioning Therapy Behavior Modification Behavior or Life Style Modifications Behavior Therapy Behavioral Interventions Behavioral Modification Behavioral Therapy Behavioral Treatment Behavioral Treatments standard of care standard therapy Quality of Life Assessment

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* PROVIDERS: Work with cancer survivors (e.g., radiation and medical oncologists, oncology nurses, oncology patient navigators, and clinical research coordinators)
* PROVIDERS: Place of engagement falls within a rural county in Texas
* PROVIDERS: Able to read, speak, and write in English
* PROVIDERS: At least 18 years old
* PROVIDERS: Have access to a smartphone, tablet, or computer with internet access and willing to attend virtual sessions
* INTERVIEW SURVIVORS: Men and women \>= 18 years of age
* INTERVIEW SURVIVORS: History of cancer
* INTERVIEW SURVIVORS: Currently receiving treatment or have recently completed treatment but are still attending appointments at UTHealth North Campus Tyler (=\< 1 year)
* INTERVIEW SURVIVORS: Able to read, speak, and write in English
* INTERVIEW SURVIVORS: Have access to a smartphone, tablet, or computer with internet access and willing to attend virtual sessions
* INTERVENTION SURVIVORS: Men and women \>= 18 years of age
* INTERVENTION SURVIVORS: Received a solid tumor cancer diagnosis stage I-III
* INTERVENTION SURVIVORS: Receiving radiation therapy or planning to receive radiation therapy for a solid tumor diagnosis for at least 4 weeks
* INTERVENTION SURVIVORS: Able to engage in moderate intensity physical activity as determined by the Physical Activity Readiness Questionnaire (PAR-Q) or by physicians clearance (letter from physician or nurse practitioner)
* INTERVENTION SURVIVORS: Physician clearance to participate in the study
* INTERVENTION SURVIVORS: Physically inactive (=\< 60 minutes of moderate or greater physical activity \[PA\] per week during the past 6 months)
* INTERVENTION SURVIVORS: Live within MD Anderson's rural catchment area
* INTERVENTION SURVIVORS: Have a home address where information can be mailed and a working telephone
* INTERVENTION SURVIVORS: Have access to a smartphone, tablet, or computer with internet access and willing to attend virtual sessions
* INTERVENTION SURVIVORS: Able to read, speak, and write in English
* INTERVENTION SURVIVORS: Able to receive text messages on their smartphone (via cellular data or wireless internet)

Exclusion Criteria

* PROVIDERS: Does not work with cancer survivors
* PROVIDERS: Place of work or engagement falls within an urban/metropolitan county in Texas
* PROVIDERS: Does not read, speak, or write in English
* PROVIDERS: Below the age of 18 years
* INTERVIEW SURVIVORS: No history of cancer
* INTERVIEW SURVIVORS: Does not read, speak, or write in English
* INTERVIEW SURVIVORS: Below the age of 18
* INTERVENTION SURVIVORS: No history of cancer
* INTERVENTION SURVIVORS: Have absolute contraindications to unassisted physical activity (e.g., acute myocardial infarction, severe orthopedic or musculoskeletal limitations)
* INTERVENTION SURVIVORS: Currently participating in another intervention to increase physical activity or reduce sedentary behavior
* INTERVENTION SURVIVORS: Self-report meeting physical activity recommendations (\>= 60 minutes of moderate or greater PA per week during the past 6 months)
* INTERVENTION SURVIVORS: Physical limitations that might be aggravated by participation in moderate-intensity physical activity as measured using the Physical Activity Readiness Questionnaire (PAR-Q), and any physical limitation that prevents engaging in moderate intensity exercise
* INTERVENTION SURVIVORS: Primary address falls within an urban/metropolitan county in Texas
* INTERVENTION SURVIVORS: Plan to move from the area or discontinue their treatment at UTHealth North Campus Tyler during the 14-week study period
* INTERVETION SURVIVORS: Does not read, speak, or write in English
* INTERVENTION SURVIVORS: Below the age of 18
* INTERVENTION SURVIVORS: Pregnant or planning to become pregnant during the 14 week study period
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

Kawut, Steven, MD

INDIV

Sponsor Role collaborator

M.D. Anderson Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Scherezade Mama, MD

Role: PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

M D Anderson Cancer Center

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Informed Consent Form

View Document

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mdanderson.org

M D Anderson Cancer Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2021-09572

Identifier Type: REGISTRY

Identifier Source: secondary_id

2020-1278

Identifier Type: OTHER

Identifier Source: secondary_id

K07CA222335

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R01HL142732

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2020-1278

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exercise and Pain in CCS
NCT05562193 COMPLETED NA